| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 02/23/2006 | WO2006019673A2 Jiadifenin analogs and uses thereof |
| 02/23/2006 | WO2006018815A1 Piperazine derivatives as adrenergic receptor antagonists |
| 02/23/2006 | WO2006018284A1 Compounds and compositions useful as cathepsin s inhibitors |
| 02/23/2006 | WO2005003086A3 Sulfonic acid derivatives of polycyclic dyes used for analytical applications |
| 02/23/2006 | US20060041136 alpha-(2-chlorophenyl)-6,7dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid methyl ester (clopidogrel hydrogen sulphate); separating crystalline form out of a solution of clopidogrel in the form of the free base in a 2-propanol or n-butyl acetate solvent by adding sulphuric acid |
| 02/23/2006 | US20060041129 Enantiomers of selected fused heterocyclics and uses thereof |
| 02/23/2006 | US20060041128 Selected fused heterocyclics and uses thereof |
| 02/23/2006 | US20060041123 Antibacterial agents |
| 02/23/2006 | US20060040964 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders |
| 02/23/2006 | US20060040961 N-isopropyl-5-phenyl-6-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)furo[2,3-d]pyrimidin-4-amine; inflammation, inhibition of T cell activation, proliferation, arthritis, organ transplant, ischemic or reperfusion injury, myocardial infarction, stroke, multiple sclerosis, inflammatory bowel disease, Crohn's |
| 02/23/2006 | US20060040960 (3-amino-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-2-yl)-(2,5-dimethoxyphenyl)methanone; antiproliferative agent; solid tumors: breast, respiratory tract, brain, reproductive organs, digestive tract, liver, skin, head and neck, thyroid, and their metastases; lymphomas, sarcomas, and leukemias |
| 02/23/2006 | US20060040949 Treating antibiotic resistant bacterial infections; compounds based on quinoline rings; (3S)-2-(3-{[(Benzo[1,2,5]thiadiazol-5-ylmethyl)-amino]-methyl}-piperidin-1-yl)-(1RS)-(6-methoxy-quinolin-4-yl)-ethanol for example |
| 02/23/2006 | US20060040948 Cognitive or neurodegenerative disease; Alzheimer's disease; HMG-CoA reductase inhibitors, gamma-secretase inhibitors, non-steroidal anti-inflammatory agents, N-methyl-D-aspartate receptor antagonists, cholinesterase inhibitors and anti-amyloid antibodies |
| 02/23/2006 | US20060040930 Novel substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same |
| 02/23/2006 | US20060040925 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 02/23/2006 | US20060040918 Benzo d!azepine derivatives for the treatment of neurological disorders |
| 02/23/2006 | US20060040900 R(-)-10-methoxy-11-O-acetyl-N-n-propyl-noraporphine; Parkinson's disease, sexual dysfunction, and depressive disorders |
| 02/23/2006 | DE102004039382A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives |
| 02/23/2006 | CA2577060A1 Substituted benzofused heterocycles |
| 02/23/2006 | CA2576421A1 Inhibitors of hcv replication |
| 02/23/2006 | CA2575826A1 Compounds and compositions useful as cathepsin s inhibitors |
| 02/22/2006 | EP1627069A2 Methods for the isolation and purification of ansamitocins |
| 02/22/2006 | EP1626970A1 Azabicycloalkane compounds as muscarinic receptor antagonists |
| 02/22/2006 | EP1626967A1 Substituted pyrazoles |
| 02/22/2006 | CN1738824A CCR1 antagonists for the treatment of I.A. demyelinating inflammatory disease |
| 02/22/2006 | CN1738814A Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 02/22/2006 | CN1738799A Methods for preparing phenylalkyne derivatives |
| 02/22/2006 | CN1243003C Aspertoxin P as compound with antineoplastic activity |
| 02/22/2006 | CN1242995C Novel compounds, their use and preparation |
| 02/21/2006 | US7001911 Fused cyclic modulators of nuclear hormone receptor function |
| 02/21/2006 | US7001906 Pyrrolo (2,3-B) pyridine derivatives containing Pyran ring, useful as anticancer compounds |
| 02/16/2006 | WO2006016203A1 An improved process for the preparation of irinotecan hydrochloride trihydrate |
| 02/16/2006 | WO2005103057A8 6,7-dihydroxy-8-phenyl-3,6,7,8-tetrahydro-chromeno[7, 8-d]imidazole derivatives and their use as gastric acid secretion inhibitors |
| 02/16/2006 | WO2005097107A8 Diphenyl - indol-2-on compounds and their use in the treatment of cancer |
| 02/16/2006 | WO2004015119A3 Methods for the isolation and purification of ansamitocins |
| 02/16/2006 | US20060036094 Method for producing zoanthamine alkaloid and intermediate used in same |
| 02/16/2006 | US20060036091 synthetic metabolites of CCI-779; for detecting CCI-779 metabolites in samples; generating CCI-779 reduction and hydroxylation derivatives using a CYP3A4 isozyme system |
| 02/16/2006 | US20060035945 Prevent reproduction, infection of virus; antitumor agents |
| 02/16/2006 | US20060035935 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/16/2006 | US20060035925 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/16/2006 | US20060035919 4-[4-(4-Amino-phenyl)-3-oxo-3,5-dihydro-pyrazolo[4,3-c]quinolin-2-yl]-benzoic acid methyl ester; rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosis and psoriasis; CD80 antagonists capable of inhibiting the interactions between CD80 and CD28 |
| 02/16/2006 | US20060035892 Nitrosated imidazopyridines |
| 02/16/2006 | US20060035884 N-cyclic sulfonamido inhibitors of gamma secretase |
| 02/16/2006 | US20060035883 Novel serotonin receptor ligands and their uses thereof |
| 02/15/2006 | EP1626041A2 New materials useful as electolytic solutes |
| 02/15/2006 | EP1624874A2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/15/2006 | CN1735619A Spirocyclic cyclohexane compounds |
| 02/15/2006 | CN1735618A New tricyclic derivatives as LTD4 antagonists |
| 02/15/2006 | CN1735617A Quinazoline derivatives as SRC tyrosine kinase inhibitors |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1733722A Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 02/15/2006 | CN1241927C Efficient method for refining tetrodotoxin by liquid-phase method |
| 02/15/2006 | CN1241926C Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 02/15/2006 | CN1241925C New [3,4-a: 3.4-c] carbazole compound, its preparation method and drug composition containing them |
| 02/15/2006 | CN1241924C Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
| 02/15/2006 | CN1241923C Method for extracting total alkaloid of corydalis rhizome and its new usage |
| 02/14/2006 | US6998485 3a,8a-Bis-azidomethyl-3a,4,8a,9-tetrahydro-3H,8H-bis[1,2,3]triazolo[1,5-a;1'',5''-d]pyrazine; provides low molecular weight energetic compounds with multiple energetic groups |
| 02/14/2006 | US6998406 Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments |
| 02/14/2006 | US6998256 Methods of obtaining epothilone D using crystallization and /or by the culture of cells in the presence of methyl oleate |
| 02/14/2006 | CA2209825C Heterocyclic-fused pyridines |
| 02/14/2006 | CA2135926C Substituted hexahydrobenzo[a]phenanthridines |
| 02/09/2006 | WO2006014135A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 02/09/2006 | WO2006013546A2 Process for the preparation of pure galantamine |
| 02/09/2006 | WO2005095409A3 Tetrahydroquinoline derivatives and a process for preparing the same |
| 02/09/2006 | WO2003090691A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 02/09/2006 | US20060030616 Anhydride modified cantharidin analogues useful in the treatment of cancer |
| 02/09/2006 | US20060030598 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 02/09/2006 | US20060030580 Contacting phenolic piperidines with opioid receptors; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction |
| 02/09/2006 | US20060030571 Ecteinascidins |
| 02/09/2006 | US20060030557 Substituted pyridines having antiangiogenic activity |
| 02/09/2006 | US20060030543 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 02/09/2006 | CA2576109A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 02/09/2006 | CA2575100A1 Heterocyclic compounds |
| 02/08/2006 | EP1623987A1 Fused pyrido[3',2':4,5]thieno[3,2-d]pyrimidines and pyrido[3',2':4,5]furo[3,2-d]pyrimidines |
| 02/08/2006 | EP1623986A1 Use of vinca alkaloid and its salt |
| 02/08/2006 | EP1622913A1 Heterocyclic compounds for use in the treatment of viral infections |
| 02/08/2006 | EP1622905A1 Imidazopyridine intermediates |
| 02/08/2006 | EP1622876A1 Cannabinoid receptor ligands and uses thereof |
| 02/08/2006 | EP1622865A2 Novel bioisosteres of actinonin |
| 02/08/2006 | EP1622569A2 Aza spiro alkane derivatives as inhibitors of metallproteases |
| 02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
| 02/08/2006 | CN1732163A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/08/2006 | CN1732147A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/08/2006 | CN1240702C Process for extracting tetrodosin with high output rate |
| 02/08/2006 | CN1240700C Aromatic heterocyclic carboxylic acid derivative, preparing method and application in medicine |
| 02/08/2006 | CN1240679C 2- and 2,5-substituted phenylketoenols |
| 02/07/2006 | US6995174 for inhibiting proteases |
| 02/07/2006 | US6995167 Arylkylamine spirofuropyridines useful in therapy |
| 02/07/2006 | US6995163 having an excellent corticotrophin-releasing-factor receptor antagonistic activity; for treating or preventing depression, nerve system disorders, schizophrenia, peptic ulcer, irritable bowel syndrome |
| 02/07/2006 | CA2200433C Phenyloxazolidinone antimicrobials |
| 02/07/2006 | CA2119783C Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase |
| 02/02/2006 | WO2006012473A1 Dynamic knowledge-based networking system and method |
| 02/02/2006 | WO2006012310A2 Carbazole derivatives for treating polycystic kidney disease |
| 02/02/2006 | WO2006012173A1 Amido compounds and their use as pharmaceuticals |
| 02/02/2006 | WO2006011040A1 Quinazolin-4-yl- piperidine and cinnolin-4-yl- piperidine derivatives as pde10 inhibitors for the treatment of cns disorders |
| 02/02/2006 | US20060025603 A reactant/solvent dimethyl formamide is made slightly basic, heating the solution to reduce the water content, then cooling, adding the hexanitrostilbene, heating to a predetermined temperature, cooling and filtering to accumulate 2,4,7,9-tetranitro-10H-benzo[4,5]furo[3,2]indole product |
| 02/02/2006 | US20060025600 Process for preparing zolmitriptan compounds |
| 02/02/2006 | US20060025588 Directly hydrogenating a heteroaryl alpha-hydroxyacetamide in the presence of a strong acid, a halide and a catalyst; for example, the heteroaryl acetamide is zolpidem and the heteroaryl alpha-hydroxyacetamide is alpha-hydroxyzolpidem |
| 02/02/2006 | US20060025435 Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 02/02/2006 | US20060025428 Bicyclic heteroaromatic compounds as kinase inhibitors |